Airway reactivity to inhaled mannitol in cigarette smokers: A longitudinal study

Respiratory Medicine

Volumn 101, Issue 7, 2007, Pages 1470-1476

  Stolz, Daiana ^a   Anderson, Sandra D ^b   Gysin, Christian ^a   Miedinger, David ^a   Surber, Christian ^a   Tamm, Michael ^a   D Leuppi, Jörg ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Airway inflammation; Airway reactivity; Cigarette smoking; Provocation test

Indexed keywords

AMFEBUTAMONE; MANNITOL; NICOTINE;

ADULT; AGE; AGED; ARTICLE; ASTHMA; ATOPY; BRONCHUS HYPERREACTIVITY; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING CESSATION PROGRAM; SYMPTOM; TOBACCO DEPENDENCE;

ADULT; AGED; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LONGITUDINAL STUDIES; MALE; MANNITOL; MIDDLE AGED; PROSPECTIVE STUDIES; SKIN TESTS; SMOKING; SMOKING CESSATION; VITAL CAPACITY;

EID: 34249738747     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.01.008     Document Type: Article

References (46)

1. Office U.G.P. The health consequences of smoking: the changing cigarette (1981), US Public Health Service, Washington
2. Office G.P. Smoking and health-a report of the Surgeon General (1979), US Public Health Service, Washington
3. Office U.G.P. The health consequences of smoking (1975), US Government Printing Office, Washington
4. Rahman I., and MacNee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 51 (1996) 348-350
5. Chalmers G.W., MacLeod K.J., Thomson L., Little S.A., McSharry C., and Thomson N.C. Smoking and airway inflammation in patients with mild asthma. Chest 120 (2001) 1917-1922
6. Willemse B.W., Postma D.S., Timens W., and ten Hacken N.H. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 23 (2004) 464-476
7. 1. Eur Respir J 2 (1989) 811-816
8. Sunyer J., Anto J.M., Kogevinas M., Soriano J.B., Tobias A., and Munoz A. Smoking and bronchial responsiveness in nonatopic and atopic young adults. Spanish group of the european study of asthma. Thorax 52 (1997) 235-238
9. Gerrard J.W., Cockcroft D.W., Mink J.T., Cotton D.J., Poonawala R., and Dosman J.A. Increased nonspecific bronchial reactivity in cigarette smokers with normal lung function. Am Rev Respir Dis 122 (1980) 577-581
10. Malo J.L., Filiatrault S., and Martin R.R. Bronchial responsiveness to inhaled methacholine in young asymptomatic smokers. J Appl Physiol 52 (1982) 1464-1470
11. Willemse B.W., ten Hacken N.H., Rutgers B., Lesman-Leegte I.G., Timens W., and Postma D.S. Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD. Eur Respir J 24 (2004) 391-396
12. Kabiraj M.U., Simonsson B.G., Groth S., Bjorklund A., Bulow K., and Lindell S.E. Bronchial reactivity, smoking, and alpha1-antitrypsin. A population-based study of middle-aged men. Am Rev Respir Dis 126 (1982) 864-869
13. Cerveri I., Bruschi C., Zoia M.C., et al. Smoking habit and bronchial reactivity in normal subjects. A population-based study. Am Rev Respir Dis 140 (1989) 191-196
14. Paoletti P., Carrozzi L., Viegi G., et al. Distribution of bronchial responsiveness in a general population: effect of sex, age, smoking, and level of pulmonary function. Am J Respir Crit Care Med 151 (1995) 1770-1777
15. Sparrow D., O'Connor G.T., Rosner B., Segal M.R., and Weiss S.T. The influence of age and level of pulmonary function on nonspecific airway responsiveness. The Normative Aging Study. Am Rev Respir Dis 143 (1991) 978-982
16. Rijcken B., Schouten J.P., Weiss S.T., Speizer F.E., and van der Lende R. The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample. Am Rev Respir Dis 136 (1987) 62-68
17. 1 in male smokers and ex-smokers. Thorax 40 (1985) 9-16
18. Lim T.K., Taylor R.G., Watson A., Joyce H., and Pride N.B. Changes in bronchial responsiveness to inhaled histamine over four years in middle aged male smokers and ex-smokers. Thorax 43 (1988) 599-604
19. Wise R.A., Kanner R.E., Lindgren P., et al. The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study. Chest 124 (2003) 449-458
20. Krzyzanowski M., and Lebowitz M.D. Changes in chronic respiratory symptoms in two populations of adults studied longitudinally over 13 years. Eur Respir J 5 (1992) 12-20
21. Brannan J.D., Gulliksson M., Anderson S.D., Chew N., and Kumlin M. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 22 (2003) 491-496
22. Brannan J.D., Anderson S.D., Gomes K., King G.G., Chan H.K., and Seale J.P. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol. Am J Respir Crit Care Med 163 (2001) 1420-1425
23. Brannan J.D., Anderson S.D., Freed R., Leuppi J.D., Koskela H., and Chan H.K. Nedocromil sodium inhibits responsiveness to inhaled mannitol in asthmatic subjects. Am J Respir Crit Care Med 161 (2000) 2096-2099
24. Brannan J.D., Koskela H., Anderson S.D., and Chan H.K. Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology 7 (2002) 37-44
25. Koskela H.O., Hyvarinen L., Brannan J.D., Chan H.K., and Anderson S.D. Sensitivity and validity of three bronchial provocation tests to demonstrate the effect of inhaled corticosteroids in asthma. Chest 124 (2003) 1341-1349
26. Leuppi J.D., Salome C.M., Jenkins C.R., et al. Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma. Eur Respir J 18 (2001) 444-450
27. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 136 (1987) 225-244
28. Dreborg S., Backmann A., Basomba A., et al. Skin tests used in type I allergy testing: position paper. EAACI subcommittee on skin tests. Allergy 44 supp10 (1989) 1-59
29. Anderson S.D., Brannan J., Spring J., et al. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 156 (1997) 758-765
30. Brannan J.D., Anderson S.D., Perry C.P., Freed-Martens R., Lassig A.R., and Charlton B. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res 6 (2005) 144
31. Skold C.M., Blaschke E., and Eklund A. Transient increases in albumin and hyaluronan in bronchoalveolar lavage fluid after quitting smoking: possible signs of reparative mechanisms. Respir Med 90 (1996) 523-529
32. Skold C.M., Hed J., and Eklund A. Smoking cessation rapidly reduces cell recovery in bronchoalveolar lavage fluid, while alveolar macrophage fluorescence remains high. Chest 101 (1992) 989-995
33. Skold C.M., Forslid J., Eklund A., and Hed J. Metabolic activity in human alveolar macrophages increases after cessation of smoking. Inflammation 17 (1993) 345-352
34. Pesci A., Rossi G.A., Bertorelli G., Aufiero A., Zanon P., and Olivieri D. Mast cells in the airway lumen and bronchial mucosa of patients with chronic bronchitis. Am J Respir Crit Care Med 149 (1994) 1311-1316
35. Leuppi J.D., Salome C.M., Jenkins C.R., et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 163 (2001) 406-412
36. Taube C., Holz O., Mucke M., Jorres R.A., and Magnussen H. Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 1810-1815
37. Simonsson B.G., and Rolf C. Bronchial reactivity to methacholine in ten non-obstructive heavy smokers before and up to one year after cessation of smoking. Eur J Respir Dis 63 (1982) 526-534
38. Buczko G.B., Day A., Vanderdoelen J.L., Boucher R., and Zamel N. Effects of cigarette smoking and short-term smoking cessation on airway responsiveness to inhaled methacholine. Am Rev Respir Dis 129 (1984) 12-14
39. Israel R.H., Ossip-Klein D.J., Poe R.H., et al. Bronchial provocation tests before and after cessation of smoking. Respiration 54 (1988) 247-254
40. Persson M.G., Zetterstrom O., Agrenius V., Ihre E., and Gustafsson L.E. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 343 (1994) 146-147
41. Johnson P.R., and Burgess J.K. Airway smooth muscle and fibroblasts in the pathogenesis of asthma. Curr Allergy Asthma Rep 4 (2004) 102-108
42. Yager D., Shore S., and Drazen J.M. Airway luminal liquid. Sources and role as an amplifier of bronchoconstriction. Am Rev Respir Dis 143 (1991) S52-S54
43. Hogman M., Holmkvist T., Walinder R., et al. Increased nitric oxide elimination from the airways after smoking cessation. Clin Sci (Lond) 103 (2002) 15-19
44. Sparrow D., O'Connor G.T., Rosner B., and Weiss S.T. Predictors of longitudinal change in methacholine airway responsiveness among middle-aged and older men: the Normative Aging Study. Am J Respir Crit Care Med 149 (1994) 376-381
45. Hospers J.J., Postma D.S., Rijcken B., Weiss S.T., and Schouten J.P. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 356 (2000) 1313-1317
46. Townsend C.O., Clark M.M., Jett J.R., et al. Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer 103 (2005) 2154-2162